| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 11/27/1996 | EP0743853A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 11/19/1996 | US5576289 Methods for treating motor deficits |
| 11/14/1996 | WO1996035805A2 Tripeptidylpeptidase inhibitors |
| 11/14/1996 | CA2221035A1 Tripeptidylpeptidase inhibitors |
| 11/12/1996 | US5574046 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 10/31/1996 | WO1996033709A1 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines |
| 10/31/1996 | WO1996033678A1 Triacetin as a transdermal penetration enhancer |
| 10/30/1996 | EP0739342A1 Pyridine modulators of acetylcholine receptors |
| 10/30/1996 | EP0739206A1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
| 10/24/1996 | WO1996033280A1 An adenovirus helper-virus system |
| 10/24/1996 | CA2218610A1 An adenovirus helper-virus system |
| 10/23/1996 | EP0738147A1 Application of riluzole in the treatment of mitochondrial diseases |
| 10/17/1996 | WO1996032384A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 10/17/1996 | WO1996032125A1 Methods for treating motor deficits |
| 10/16/1996 | EP0737074A1 Botulinum toxins for treating various disorders and associated pain |
| 10/15/1996 | US5565486 Administering culture product of the fungus acremonium strictum as an anticonvulsant, anxiolytic agent, muscle relaxant, hypnotic or memory enhancer |
| 10/09/1996 | EP0736032A1 Heterocyclic compounds |
| 10/09/1996 | EP0735888A1 Purine compositions and methods for administration |
| 10/01/1996 | US5561228 Immunosuppressnats; side effect reduction |
| 09/24/1996 | US5559124 Depolarizing skeletal muscle relaxants |
| 09/18/1996 | EP0731802A1 N-substituted azabicycloalkane derivatives as neuroleptika asf |
| 09/18/1996 | CN1131154A 8-oxy-5,8-dihydro-6H-dibenzo|a,g¨quinolizine-13-propionic acid derivant, its preparation method and medicinal use thereof |
| 09/04/1996 | EP0729758A2 Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 08/28/1996 | EP0728134A1 6-oxo-nucleosides useful as immunosuppressants |
| 08/27/1996 | US5550142 Phenyl heterocycles as cox-2 inhibitors |
| 08/22/1996 | WO1996025405A1 Substituted isoxazoles for the treatment of inflammation |
| 08/22/1996 | WO1996025403A1 α-SUBSTITUTED HYDRAZIDES HAVING CALPAIN INHIBITORY ACTIVITY |
| 08/22/1996 | WO1996025174A1 Muscle protein decomposition inhibitor containing il-6 receptor antibody |
| 08/22/1996 | CA2208073A1 Alpha-substituted hydrazides having calpain inhibitory activity |
| 08/21/1996 | CN1129447A Tri-substituted imidazoles having multiple therapeutic properties |
| 08/14/1996 | CN1128992A Therapeutic agents |
| 08/08/1996 | WO1996023410A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 08/01/1996 | CA2155043A1 Anti-motoneuron-disease agent |
| 07/23/1996 | US5538844 Transport protein gene from the Huntington's disease region |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/17/1996 | EP0721349A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 07/17/1996 | EP0721348A1 Monoglyceride/lactate ester permeation enhancer |
| 07/16/1996 | US5536832 N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions containing them and process for preparing same |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/11/1996 | WO1996020941A1 Hydroxymethylimidazodiazepines and their esters |
| 07/11/1996 | CA2209424A1 Hydroxymethylimidazodiazepines and their esters |
| 07/04/1996 | WO1996020176A1 Huperzine a derivatives, their preparation and their use |
| 07/03/1996 | EP0719776A1 8-Oxo-5,8-dihydro-6H-dibenzo(a,g) quinolizine-13-propanoic acid derivatives, their preparation and therapeutic use |
| 07/03/1996 | EP0719558A1 Ranolazine and related piperazines for use in the treatment of shock conditions |
| 07/03/1996 | EP0719268A1 K-252a DERIVATIVES WHICH ENHANCE NEUROTROPHIN-INDUCED ACTIVITY |
| 07/03/1996 | CN1125945A Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 07/03/1996 | CN1125938A Bicyclic amide derivatives and their use as muscle relaxants |
| 07/03/1996 | CN1125725A First-kind "Haikelin" alkali derivant and its usage |
| 07/03/1996 | CN1125596A Far-infrared radiation magnetic permeated ointment and its preparation method |
| 07/02/1996 | US5532236 [1,2,4]triazolo[4,3-a]quinoxaline compounds |
| 06/30/1996 | CA2166233A1 8-oxo-5,8-dihydro-6h-dibenzo¬a,g|quinolizine-13-propanoic acid derivatives, their preparation and their therapeutic application |
| 06/26/1996 | EP0717623A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
| 06/26/1996 | CN1125446A |1,2,4¨triazolo|4,3-a¨quinoxaline compounds, their preparation and use |
| 06/25/1996 | US5530101 Humanized immunoglobulins |
| 06/19/1996 | CN1124654A External use medicine for traumatic injuries |
| 06/18/1996 | US5527814 Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis |
| 06/05/1996 | EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles |
| 05/30/1996 | WO1996007410A3 Depolarizing skeletal muscle relaxants |
| 05/28/1996 | CA2041330C Percutaneously absorbable eperisone or tolperisone preparation |
| 05/23/1996 | WO1996015129A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments |
| 05/23/1996 | WO1996015123A1 Pyridine modulators of acetylcholine receptors |
| 05/23/1996 | WO1996015103A1 Diaminocyclobutene-3,4-diones |
| 05/23/1996 | WO1996014857A1 Multicatalytic protease inhibitors |
| 05/23/1996 | CA2202760A1 Multicatalytic protease inhibitors |
| 05/22/1996 | EP0539470B1 Neuromuscular blocking agents |
| 05/14/1996 | US5516785 Anabaseine, stimulating brain cholinergic transmission |
| 05/14/1996 | US5516772 K-252 derivatives which enhance neurotrophin-induced activity |
| 05/09/1996 | WO1996013492A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives |
| 05/09/1996 | WO1996013257A1 Use of receptor potentiators |
| 05/09/1996 | CA2200886A1 Use of ner receptors potentiators |
| 05/07/1996 | US5514661 Autoimmune disease treatment |
| 05/01/1996 | EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 04/24/1996 | EP0707586A1 Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 04/24/1996 | EP0707570A1 Isoquinoline derivatives as therapeutic agents |
| 04/23/1996 | US5510355 Depolarizing skeletal muscle relaxants |
| 04/17/1996 | EP0706566A1 Conotoxins having acetylcholin receptor binding properties |
| 04/16/1996 | US5508265 Administering to prevent accumulation of excess, extracellular free actin and to inhibit secondary tissue injury |
| 04/11/1996 | WO1996010568A1 Substituted aryl piperazines as neurokinin antagonists |
| 04/11/1996 | CA2199621A1 Substituted aryl piperazines as neurokinin antagonists |
| 04/09/1996 | US5506243 Sulfonamide derivatives |
| 04/09/1996 | US5506229 Skeletal and muscle disorders |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0426714B1 Acetylenic imidazoles having central nervous system activity |
| 03/27/1996 | EP0702681A1 Spiro-substituted azacycles as neurokinin antagonists |
| 03/27/1996 | EP0702561A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 03/27/1996 | EP0702559A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions |
| 03/14/1996 | WO1996007410A2 Depolarizing skeletal muscle relaxants |
| 03/07/1996 | WO1996006606A1 Dihydro-2,3-benzodiazepine derivatives |
| 03/06/1996 | EP0699180A1 Bicyclic amide derivatives and their use as muscle relaxants |
| 03/06/1996 | EP0699078A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
| 02/28/1996 | CN1031132C Process for preparation of carbocyclic adenosine analogs useful as immunosuppressants |
| 02/27/1996 | US5494915 Isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same |
| 02/27/1996 | CA1338089C Sulfonic acid esters |
| 02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
| 02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
| 02/01/1996 | WO1996002233A1 Immunological activity of rhamnolipids |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |